623 related articles for article (PubMed ID: 12714638)
1. Expression of classic and nonclassic HLA class I antigens in uveal melanoma.
Anastassiou G; Rebmann V; Wagner S; Bornfeld N; Grosse-Wilde H
Invest Ophthalmol Vis Sci; 2003 May; 44(5):2016-9. PubMed ID: 12714638
[TBL] [Abstract][Full Text] [Related]
2. HLA expression in uveal melanoma: there is no rule without some exception.
Jager MJ; Hurks HM; Levitskaya J; Kiessling R
Hum Immunol; 2002 Jun; 63(6):444-51. PubMed ID: 12039519
[TBL] [Abstract][Full Text] [Related]
3. Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma.
Blom DJ; Luyten GP; Mooy C; Kerkvliet S; Zwinderman AH; Jager MJ
Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1865-72. PubMed ID: 9286277
[TBL] [Abstract][Full Text] [Related]
4. Expression pattern of HLA class I antigens in renal cell carcinoma and primary cell line cultures: methodological implications for immunotherapy.
Hanak L; Slaby O; Lauerova L; Kren L; Nenutil R; Michalek J
Med Sci Monit; 2009 Dec; 15(12):CR638-43. PubMed ID: 19946235
[TBL] [Abstract][Full Text] [Related]
5. Inverse correlation between expression of HLA-B and c-myc in uveal melanoma.
Blom DJ; Mooy CM; Luyten GP; Kerkvliet S; Ouwerkerk I; Zwinderman AH; Schrier PI; Jager MJ
J Pathol; 1997 Jan; 181(1):75-9. PubMed ID: 9072006
[TBL] [Abstract][Full Text] [Related]
6. Uveal melanoma: no expression of HLA-G.
Hurks HM; Valter MM; Wilson L; Hilgert I; van den Elsen PJ; Jager MJ
Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3081-4. PubMed ID: 11726606
[TBL] [Abstract][Full Text] [Related]
7. Major histocompatibility antigens and antigen-processing molecules in uveal melanoma.
Krishnakumar S; Abhyankar D; Sundaram AL; Pushparaj V; Shanmugam MP; Biswas J
Clin Cancer Res; 2003 Sep; 9(11):4159-64. PubMed ID: 14519640
[TBL] [Abstract][Full Text] [Related]
8. Detection efficacy of soluble HLA-A, B antigens using 1D-IEF.
Kubens BS; Pässler M; Grosse-Wilde H
Eur J Immunogenet; 1994 Dec; 21(6):469-77. PubMed ID: 9098457
[TBL] [Abstract][Full Text] [Related]
9. Association of HLA class I and class II antigen expression and mortality in uveal melanoma.
Ericsson C; Seregard S; Bartolazzi A; Levitskaya E; Ferrone S; Kiessling R; Larsson O
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2153-6. PubMed ID: 11527924
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of HLA class II antigens on human uveal melanoma cells after in vivo X-ray irradiation.
Jager MJ; van der Pol JP; de Wolff-Rouendaal D; de Jong PT; Ruiter DJ
Am J Ophthalmol; 1988 Jan; 105(1):78-86. PubMed ID: 3276205
[TBL] [Abstract][Full Text] [Related]
11. HLA expression and tumor-infiltrating immune cells in uveal melanoma.
de Waard-Siebinga I; Hilders CG; Hansen BE; van Delft JL; Jager MJ
Graefes Arch Clin Exp Ophthalmol; 1996 Jan; 234(1):34-42. PubMed ID: 8750848
[TBL] [Abstract][Full Text] [Related]
12. HLA antigen expression on uveal melanoma cells in vivo and in vitro.
de Waard-Siebinga I; Kool J; Jager MJ
Hum Immunol; 1995 Oct; 44(2):111-7. PubMed ID: 8847229
[TBL] [Abstract][Full Text] [Related]
13. [HLA class I antigen expression correlates with histological cell type in uveal melanoma].
Dithmar S; Crowder J; Jager MJ; Vigniswaran N; Grossniklaus HE
Ophthalmologe; 2002 Aug; 99(8):625-8. PubMed ID: 12227276
[TBL] [Abstract][Full Text] [Related]
14. HLA Class I and II genotype in uveal melanoma: relation to occurrence and prognosis.
Maat W; Haasnoot GW; Claas FH; Schalij-Delfos NE; Schreuder GM; Jager MJ
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):3-6. PubMed ID: 16384937
[TBL] [Abstract][Full Text] [Related]
15. HLA expression in a primary uveal melanoma, its cell line, and four of its metastases.
Blom DJ; Schurmans LR; De Waard-Siebinga I; De Wolff-Rouendaal D; Keunen JE; Jager MJ
Br J Ophthalmol; 1997 Nov; 81(11):989-93. PubMed ID: 9505825
[TBL] [Abstract][Full Text] [Related]
16. HLA-A, -B, -C genotyping and expression in human nonlymphoid tumor cell lines.
Delfino L; Ciccarelli G; Bini D; Morabito A; Pozzi S; Martayan A; Giorda E; Setini A; Fraioli R; Giacomini P; Ferrara GB
J Immunother; 1999 Jan; 22(1):7-15. PubMed ID: 9924694
[TBL] [Abstract][Full Text] [Related]
17. High frequency of allele-specific down-regulation of HLA class I expression in uveal melanoma cell lines.
Hurks HM; Metzelaar-Blok JA; Mulder A; Claas FH; Jager MJ
Int J Cancer; 2000 Mar; 85(5):697-702. PubMed ID: 10699951
[TBL] [Abstract][Full Text] [Related]
18. Analysis of HLA antigen expression in benign and malignant melanocytic lesions reveals that upregulation of HLA-G expression correlates with malignant transformation, high inflammatory infiltration and HLA-A1 genotype.
Ibrahim EC; Aractingi S; Allory Y; Borrini F; Dupuy A; Duvillard P; Carosella ED; Avril MF; Paul P
Int J Cancer; 2004 Jan; 108(2):243-50. PubMed ID: 14639610
[TBL] [Abstract][Full Text] [Related]
19. Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients.
Maat W; van der Slik AR; Verhoeven DH; Alizadeh BZ; Ly LV; Verduijn W; Luyten GP; Mulder A; van Hall T; Koning F; Jager MJ; van Bergen J
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2888-95. PubMed ID: 19234348
[TBL] [Abstract][Full Text] [Related]
20. Expression of HLA antigens in paraffin sections of uveal melanomas.
Jager MJ; de Wolff-Rouendaal D; Breebaart AC; Ruiter DJ
Doc Ophthalmol; 1986 Dec; 64(1):69-76. PubMed ID: 3556115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
